SION - NASDAQ

Sionna Therapeutics, Inc.

SION·NASDAQ

$36.70

-10%

HealthcareBiotechnology

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.66B

EPS-1.8800

P/E Ratio-19.52

Earnings Date08/10/2026

sion

Stock Based Compensation

Last Annual Value

12.07M

3-Year CAGR

93%

5-Year CAGR

48%

10-Year CAGR

22%

Adjust for Inflation

Sionna Therapeutics, Inc. Competitors Analysis of Stock Based Compensation

SION · NASDAQ

Company	Stock Based Compensation	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sionna Therapeutics, Inc. NASDAQ:SION	12.07M	74.8%	N/A	N/A
Vera Therapeutics, Inc. NASDAQ:VERA	37.93M	48.9%	66.0%	N/A
Janux Therapeutics, Inc. NASDAQ:JANX	40.22M	26.2%	42.2%	N/A
Maze Therapeutics, Inc. NASDAQ:MAZE	16.40M	23.3%	N/A	N/A
Ardelyx, Inc. NASDAQ:ARDX	48.96M	53.5%	32.4%	24.9%
Celldex Therapeutics, Inc. NASDAQ:CLDX	36.22M	14.9%	32.2%	9.0%
Immunome, Inc. NASDAQ:IMNM	25.69M	60.4%	49.4%	N/A
Xeris Biopharma Holdings, Inc. NASDAQ:XERS	22.37M	27.8%	14.5%	45.1%
Biohaven Ltd. NYSE:BHVN	112.36M	57.4%	11.4%	N/A

Sionna Therapeutics, Inc. Fair Value Envelope

SION · NASDAQ

Our analysis suggests that SION has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $36.7, this represents a potential HIDDEN relative to our calculated worth for Sionna Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $36.7

Related Guides

Blog Categories

Continue your SION research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.